SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹11.79 | ₹16.16 | ₹17.83 | ₹14.23 | ₹12.45 |
What is the latest Earnings Per Share (EPS) of SUVEN PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹11.79 |
| Mar2024 | ₹16.16 |
| Mar2023 | ₹17.83 |
| Mar2022 | ₹14.23 |
| Mar2021 | ₹12.45 |
How is Earnings Per Share (EPS) of SUVEN PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹11.79 | -27.04 | |
| Mar2024 | ₹16.16 | -9.37 | |
| Mar2023 | ₹17.83 | 25.30 | |
| Mar2022 | ₹14.23 | 14.30 | |
| Mar2021 | ₹12.45 | - | |
Compare Earnings Per Share (EPS) of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹18,169.7 Cr | -7.4% | -10.1% | -54.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -7.4% |
-10.1% |
-54.9% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses